New combo therapy shows promise for tough cervical cancers
NCT ID NCT04865887
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with advanced cervical cancer that has not responded to initial treatment. The goal is to see if this combination can shrink tumors or slow cancer growth. About 35 participants will receive the treatment, and researchers will monitor how well it works and for how long.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Georgia Cancer Center at Augusta University
RECRUITINGAugusta, Georgia, 30912, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
John Theurer Cancer Center at Hackensack UMC
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MedStar Georgetown University Hospital
RECRUITINGWashington D.C., District of Columbia, 20007, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Medstar Washington Hospital Center
WITHDRAWNWashington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.